3.4. Syntheses
3.4.1. Hexafluoroisopropylborane-dimethylsulfide Adduct (1)
The synthesis was carried out following the procedure in the literature [
42]; however, the amount of reactants used was increased by a factor of 2100, whereas the amount of solvent was only increased by a factor of 200.
Hexafluoropropene C3F6 (6.31 g, 42.0 mmol) was condensed into a solution of BH3·SMe2 (2.0 M in toluene, 20 mL, 40.0 mmol) in toluene (80 mL) at −78 °C. The reaction mixture was slowly heated to 100 °C in a closed reaction vessel under vigorous stirring and kept at this temperature for one hour. The hexafluoroisopropylborane-dimethylsulfide solution obtained was used without further purification. Yield: 100 mL of a 0.4 M solution of (CF3)(CF2H)CFBH2·SMe2 (40.0 mmol) in toluene.
11B NMR (128.43 MHz): δ = −14.6 (t, 1B, BH2, 1J(11B,1H) = 109.7 Hz) ppm; 19F NMR (376.66 MHz): δ = −75.1 (m, 3F, CF3), −128.5 (dm, 2F, CF2H, 2J(19F,1H) = 53.5 Hz), −199.6 (m, 1F, CF) ppm.
3.4.2. Hexafluoroisopropylborane-4-cyanopyridine Adduct (2)
A solution of 1 (0.2 M in toluene, 100 mL, 20.0 mmol) was added to 4-cyanopyridine (2.08 g, 20.0 mmol). After stirring for 14 h at room temperature, all volatiles were removed under reduced pressure. The solid residue was taken up into CH2Cl2 (30 mL) and washed with water (3 × 10 mL). Subsequently, the organic solvent was removed under reduced pressure and the product was dried under vacuum. Yield: 4.53 g (16.9 mmol, 85%, calculated for 1) of a light-yellow solid.
1H NMR (500.13 MHz, CD2Cl2): δ = 8.79 (d, 2H, CH, 3J(1H,1H) = 6.7 Hz), 8.79 (dm, 2H, CH, 3J(1H,1H) = 6.8 Hz), 5.95 (td, 1H, CF2H, 2J(19F,1H) = 54.6 Hz, 3J(19F,1H) = 9.2 Hz), 2.77(m, 2H, BH2) ppm; 1H{11B} NMR (500.13 MHz, CD2Cl2): δ = 8.79 (d, 2H, CH, 3J(1H,1H) = 6.7 Hz), 8.79 (d, 2H, CH, 3J(1H,1H) = 6.8 Hz)), 5.95 (td, 1H, CF2H, 2J(19F,1H) = 54.6 Hz, 3J(19F,1H) = 9.2 Hz), 2.77(d, 2H, BH2, 3J(19F,1H) = 24.7 Hz) ppm; 1H{19F} NMR (400.30 MHz, CD2Cl2): δ = 8.79 (d, 2H, CH, 3J(1H,1H) = 6.7 Hz), 8.79 (dm, 2H, CH, 3J(1H,1H) = 6.8 Hz), 5.95 (m, 1H, CF2H), 2.77(m, 2H, BH2) ppm; 11B NMR (160.46 MHz, CD2Cl2): δ = −8.8 (t, 1B, BH2, 1J(11B,1H) = 94.8 Hz) ppm; 11B{1H} NMR (160.46 MHz, CD2Cl2): δ = −8.8 (s, 1B, BH2) ppm; 11B{19F} NMR (160.46 MHz, CD2Cl2): δ = −8.8 (t, 1B, BH2, 1J(11B,1H) = 94.8 Hz) ppm; 13C{1H} NMR (125.76 MHz, CD2Cl2): δ = 150.3 (s, 2C, CH), 128.5 (s, 2C, CH), 125.9 (s, 1C, C−CN), 125.0 (qdt, 1C, CF3, 1J(19F,13C) = 284.1 Hz, 2J(19F,13C) = 25.7 Hz, 3J(19F,13C) = 5.4 Hz), 114.8 (s, 1C, CN), 114.9 (tdq, 1C, CF2H, 1J(19F,13C) = 246.3 Hz, 2J(19F,13C) = 27.2 Hz, 3J(19F,13C) = 2.9 Hz), 95.4 (d, br, 1C, CF, 1J(19F,13C) = 183.0 Hz) ppm; 13C{11B,1H} NMR (75.48 MHz, CD2Cl2): δ = 150.3 (s, 2C, CH), 128.5 (s, 2C, CH), 125.9 (s, 1C, C−CN), 125.0 (qdt, 1C, CF3, 1J(19F,13C) = 284.1 Hz, 2J(19F,13C) = 25.7 Hz, 3J(19F,13C) = 5.4 Hz), 114.9 (s, 1C, CN), 114.8 (tdq, 1C, CF2H, 1J(19F,13C) = 246.3 Hz, 2J(19F,13C) = 27.2 Hz, 3J(19F,13C) = 2.9 Hz), 95.4 (dqt, 1C, CF, 1J(19F,13C) = 183.0 Hz, 2J(19F,13C) = 28.8 Hz, 2J(19F,13C) = 25.1 Hz) ppm; 13C{19F} NMR (125.76 MHz, CD2Cl2): δ = 150.3 (d, 2C, CH, 1J(13C,1H) = 191.8 Hz), 128.5 (ddt, 2C, CH, 1J(13C,1H) = 176.2 Hz, 2J(13C,1H) = 6.5 Hz, 3J(13C,1H) = 2.7 Hz), 125.9 (t, 1C, C−CN, 3J(13C,1H) = 7.9 Hz), 125.0 (s, 1C, CF3), 114.9 (t, 1C, CN, 3J(13C,1H) = 5.3 Hz), 114.8 (d, 1C, CF2H, 1J(13C,1H) = 190.4 Hz), 95.4 (s, br, 1C, CF) ppm; 19F NMR (376.82 MHz, CD2Cl2): δ = −74.3 (dtt, 3F, CF3, 3J(19F,19F) = 10.3 Hz, 4J(19F,19F) = 7.9 Hz, 4J(19F,1H) = 2.2 Hz), −128.9 (dm, 2F, CF2H, 2J(19F,1H) = 54.2 Hz), −205.1 (tqm, 1F, CF, 3J(19F,19F) = 10.6 Hz, 3J(19F,19F) = 10.6 Hz) ppm; 19F{1H} NMR (376.82 MHz, CD2Cl2): δ = −74.3 (dt, 3F, CF3, 3J(19F,19F) = 10.3 Hz, 4J(19F,19F) = 7.9 Hz), −128.9 (m, 2F, CF2H), −205.1 (tq, 1F, CF, 3J(19F,19F) = 10.6 Hz, 3J(19F,19F) = 10.6 Hz) ppm; 19F{11B} NMR (470.59 MHz, CD2Cl2): δ = −74.3 (dtt, 3F, CF3, 3J(19F,19F) = 10.3 Hz, 4J(19F,19F) = 7.9 Hz, 4J(19F,1H) = 2.2 Hz), −128.9 (dm, 2F, CF2H, 2J(19F,1H) = 54.2 Hz), −205.1 (tqm, 1F, CF, 3J(19F,19F) = 10.6 Hz, 3J(19F,19F) = 10.6 Hz) ppm.
IR (ATR): 2464, 2430 cm−1 ((B–H)).
Raman: 2471, 2433 cm−1 ((B–H)), 2247 cm−1 ((C≡N)).
Elemental analysis: Calculated (%) for C9H7BF6N2, C 40.34, H 2.63, N 10.45; found, C 41.04, H 2.83, N 10.46.
HMRS ((–)-ESI): m/z (isotopic abundance) calculated for C9H7BF6N2: 268.06 (100.0%), 267.06 (24.8%), 269.06 (9.7%), 268.07 (2.4%); found, 268.06 (100.0%), 267.06 (25.2%), 269.06 (9.4%), 268.07 (1.0%).
Crystals of 2 suitable for an X-ray diffraction study were obtained via the slow evaporation of an acetone solution.
3.4.3. Hexafluoroisopropylborane-imidazole Adducts (3a–e)
A solution of 1 (0.4 M in toluene, 12.5 mL, 5.00 mmol) was added to the corresponding imidazole (5.00 mmol). After stirring for 48 h at room temperature, the reaction mixture was washed with water (3 × 5 mL). Subsequently, the organic phase was dried over Na2SO4, filtered, and the organic solvent was removed under reduced pressure. The product was dried under vacuum.
Hexafluoroisopropylborane-imidazole adduct 3a was prepared using imidazole (340 mg, 5.00 mmol). Yield: 963 mg (4.15 mmol, 85%, calculated for 1) of a colorless liquid.
Hexafluoroisopropylborane-imidazole-adduct 3a can also be prepared by using 1-(trimethylsilyl)imidazole (701 mg, 733 µL, 5.00 mmol). Yield: 1.03 g (4.44 mmol, 89%, calculated for 1) of a colorless liquid.
1H NMR (500.13 MHz, CD2Cl2): δ = 9.84 (s, br, 1H, NH), 8.00 (s, 1H, NCHN), 7.20 (s, br, 1H, CH), 7.15 (m, 1H, CH), 5.91 (tdq, 1H, CF2H, 2J(19F,1H) = 54.5 Hz, 3J(19F,1H) = 9.4 Hz, 4J(19F,1H) = 0.6 Hz), 2.46 (qd, 2H, BH2, 1J(11B,1H) = 99.8, 3J(19F,1H) = 26.8) ppm; 1H{11B} NMR (500.13 MHz, CD2Cl2): δ = 9.84 (s, br, 1H, NH), 8.00 (s, 1H, NCHN), 7.20 (s, br, 1H, CH), 7.15 (s, br, 1H, CH), 5.91 (td, 1H, CF2H, 2J(19F,1H) = 54.5 Hz, 3J(19F,1H) = 9.4 Hz), 2.46 (dq, 2H, BH2, 3J(19F,1H) = 26.8, 4J(19F,1H) = 2.7) ppm; 1H{19F} NMR (400.30 MHz, CD2Cl2): δ = 9.84 (s, br, 1H, NH), 8.00 (s, 1H, NCHN), 7.20 (s, br, 1H, CH), 7.15 (m, 1H, CH), 5.91 (m, 1H, CF2H), 2.46(q, 2H, BH2, 1J(11B,1H) = 99.2) ppm; 11B NMR (160.46 MHz, CD2Cl2): δ = −15.5 (t, 1B, BH2, 1J(11B,1H) = 99.8 Hz) ppm; 11B{1H} NMR (160.46 MHz, CD2Cl2): δ = −15.5 (s, 1B, BH2) ppm; 11B{19F} NMR (160.46 MHz, CD2Cl2): δ = −15.5 (t, 1B, BH2, 1J(11B,1H) = 99.8 Hz) ppm; 13C{1H} NMR (125.76 MHz, CD2Cl2): δ = 136.7 (s, 1C, NCHN), 127.9 (s, 1C, CH), 125.5 (qdt, 1C, CF3, 1J(19F,13C) = 283.6 Hz, 2J(19F,13C) = 25.9 Hz, 3J(19F,13C) = 4.9 Hz), 117.4 (s, 1C, CH), 115.3 (tdq, 1C, CF2H, 1J(19F,13C) = 246.6 Hz, 2J(19F,13C) = 27.0 Hz, 3J(19F,13C) = 2.8 Hz), 96.0 (d, br, 1C, CF, 1J(19F,13C) = 180.5 Hz) ppm; 13C{11B,1H} NMR (75.48 MHz, CD2Cl2): δ = 136.9 (s, 1C, NCHN), 125.4 (s, 1C, CH), 125.5 (qdt, 1C, CF3, 1J(19F,13C) = 283.6 Hz, 2J(19F,13C) = 25.9 Hz, 3J(19F,13C) = 4.9 Hz), 117.8 (s, 1C, CH), 115.5 (tdq, 1C, CF2H, 1J(19F,13C) = 246.6 Hz, 2J(19F,13C) = 27.0 Hz, 3J(19F,13C) = 2.8 Hz), 96.0 (dqt, 1C, CF, 1J(19F,13C) = 180.5 Hz, 2J(19F,13C) = 29.1 Hz, 2J(19F,13C) = 23.4 Hz) ppm; 13C{19F} NMR (125.76 MHz, CD2Cl2): δ = 136.7 (d, 1C, NCHN, 1J(13C,1H) = 217.8 Hz), 127.9 (dm, 1C, CH, 1J(13C,1H) = 200.3 Hz), 125.5 (s, 1C, CF3), 117.4 (dm, 1C, CH, 1J(13C,1H) = 199.3 Hz), 115.3 (dt, 1C, CF2H, 1J(13C,1H) = 188.7 Hz, 3J(13C,1H) = 3.3 Hz), 96.0 (m, br, 1C, CF) ppm; 19F NMR (376.82 MHz, CD2Cl2): δ = −73.9 (dtt, 3F, CF3, 3J(19F,19F) = 10.3 Hz, 4J(19F,19F) = 7.9 Hz, 4J(19F,1H) = 2.2 Hz), −129.5 (dm, 2F, CF2H, 2J(19F,1H) = 54.4 Hz), −205.3 (m, 1F, CF) ppm; 19F{1H} NMR (376.82 MHz, CD2Cl2): δ = −73.9 (dt, 3F, CF3, 3J(19F,19F) = 10.3 Hz, 4J(19F,19F) = 7.9 Hz), −129.5 (m, 2F, CF2H), −205.3 (m, 1F, CF) ppm; 19F{11B} NMR (470.59 MHz, CD2Cl2): δ = −73.9 (dtt, 3F, CF3, 3J(19F,19F) = 10.3 Hz, 4J(19F,19F) = 7.9 Hz, 4J(19F,1H) = 2.2 Hz), −129.5 (dm, 2F, CF2H, 2J(19F,1H) = 54.4 Hz), −205.3 (m, 1F, CF) ppm.
IR (ATR): 3447 cm−1 ((N–H)), 2414 cm−1 ((B–H)).
Raman: 2418 cm−1 ((B–H)).
Elemental analysis: Calculated (%) for C6H7BF6N2, C 31.07, H 3.04, N 12.06; found, C 31.09, H 3.07, N 12.85.
HMRS ((-)-APCI): m/z (isotopic abundance) calculated for deprotonated 3a C6H6BF6N2−: 231.05 (100.0%), 230.06 (24.8%), 232.06 (6.5%), 231.06 (1.6%); found, 231.05 (100.0%), 230.06 (23.7%), 232.06 (5.8%).
Hexafluoroisopropylborane-1-methylimidazole adduct 3b was prepared using 1-methylimidazole (410 mg, 396 µL, 5.00 mmol). Yield: 1.01 g (4.11 mmol, 82%, calculated for 1) of a colorless solid.
1H NMR (500.13 MHz, CD2Cl2): δ = 7.79 (s, 1H, NCHN), 7.10 (s, br, 1H, CH), 6.96 (m, 1H, CH), 5.88 (tdq, 1H, CF2H, 2J(19F,1H) = 54.5 Hz, 3J(19F,1H) = 9.4 Hz, 4J(19F,1H) = 0.6 Hz), 3.76 (s, 3H, CH3), 2.39 (qm, 2H, BH2, 1J(11B,1H) = 100.2) ppm; 1H{11B} NMR (500.13 MHz, CD2Cl2): δ = 7.79 (s, 1H, NCHN), 7.10 (s, br, 1H, CH), 6.96 (s, br, 1H, CH), 5.91 (td, 1H, CF2H, 2J(19F,1H) = 54.5 Hz, 3J(19F,1H) = 9.4 Hz), 3.76 (s, 3H, CH3), 2.39 (dq, 2H, BH2, 3J(19F,1H) = 27.1, 4J(19F,1H) = 2.8) ppm; 1H{19F} NMR (400.30 MHz, CD2Cl2): δ = 7.79 (s, 1H, NCHN), 7.10 (s, br, 1H, CH), 6.96 (m, 1H, CH), 5.88 (m, 1H, CF2H), 3.76 (s, 3H, CH3), 2.39 (q, 2H, BH2, 1J(11B,1H) = 100.2) ppm; 11B NMR (160.46 MHz, CD2Cl2): δ = −15.6 (t, 1B, BH2, 1J(11B,1H) = 100.2 Hz) ppm; 11B{1H} NMR (160.46 MHz, CD2Cl2): δ = −15.6 (s, 1B, BH2) ppm; 11B{19F} NMR (160.46 MHz, CD2Cl2): δ = −15.6 (t, 1B, BH2, 1J(11B,1H) = 100.2 Hz) ppm; 13C{1H} NMR (125.76 MHz, CD2Cl2): δ = 138.5 (s, 1C, NCHN), 128.4 (s, 1C, CH), 125.5 (qdt, 1C, CF3, 1J(19F,13C) = 284.2 Hz, 2J(19F,13C) = 25.9 Hz, 3J(19F,13C) = 4.8 Hz), 121.5 (s, 1C, CH), 115.4 (tdq, 1C, CF2H, 1J(19F,13C) = 246.4 Hz, 2J(19F,13C) = 26.7 Hz, 3J(19F,13C) = 2.8 Hz), 95.8 (d, br, 1C, CF, 1J(19F,13C) = 180.4 Hz), 35.5 (s, 1C, CH3) ppm; 13C{11B,1H} NMR (75.48 MHz, CD2Cl2): δ = 138.5 (s, 1C, NCHN), 128.2 (s, 1C, CH), 125.6 (qdt, 1C, CF3, 1J(19F,13C) = 284.2 Hz, 2J(19F,13C) = 25.9 Hz, 3J(19F,13C) = 4.8 Hz), 121.7 (s, 1C, CH), 115.5 (tdq, 1C, CF2H, 1J(19F,13C) = 246.4 Hz, 2J(19F,13C) = 26.7 Hz, 3J(19F,13C) = 2.8 Hz), 95.9 (dqt, 1C, CF, 1J(19F,13C) = 180.4 Hz, 2J(19F,13C) = 28.5 Hz, 2J(19F,13C) = 23.3 Hz), 35.4 (s, 1C, CH3) ppm; 13C{19F} NMR (125.76 MHz, CD2Cl2): δ = 138.5 (d, 1C, NCHN, 1J(13C,1H) = 214.9 Hz), 128.4 (dm, 1C, CH, 1J(13C,1H) = 198.8 Hz), 125.5 (s, 1C, CF3), 121.5 (dm, 1C, CH, 1J(13C,1H) = 197.9 Hz), 115.4 (dt, 1C, CF2H, 1J(13C,1H) = 189.1 Hz, 3J(13C,1H) = 3.3 Hz), 95.8 (m, br, 1C, CF), 35.5 (q, 1C, CH3, 1J(13C,1H) = 142.4 Hz) ppm; 19F NMR (376.82 MHz, CD2Cl2): δ = −74.0 (dtt, 3F, CF3, 3J(19F,19F) = 10.2 Hz, 4J(19F,19F) = 8.0 Hz, 4J(19F,1H) = 2.2 Hz), −129.7 (dm, 2F, CF2H, 2J(19F,1H) = 54.3 Hz), −205.8 (m, 1F, CF) ppm; 19F{1H} NMR (376.82 MHz, CD2Cl2): δ = −74.0 (dt, 3F, CF3, 3J(19F,19F) = 10.2 Hz, 4J(19F,19F) = 8.0 Hz), −129.7 (m, 2F, CF2H), −205.8 (m, 1F, CF) ppm; 19F{11B} NMR (470.59 MHz, CD2Cl2): δ = −74.0 (dtt, 3F, CF3, 3J(19F,19F) = 10.3 Hz, 4J(19F,19F) = 7.9 Hz, 4J(19F,1H) = 2.2 Hz), −129.5 (dm, 2F, CF2H, 2J(19F,1H) = 54.3 Hz), −205.8 (m, 1F, CF) ppm.
IR (ATR): 2395 cm−1 ((B–H)).
Raman: 2407 cm−1 ((B–H)).
Elemental analysis: Calculated (%) for C7H9BF6N2, C 34.18, H 3.69, N 11.39; found, C 34.16, H 3.61, N 11.24.
HMRS ((-)-APCI): m/z (isotopic abundance) calculated for deprotonated 3b C7H8BF6N2−: 245.07 (100.0%), 244.07 (24.8%), 246.07 (7.6%), 245.08 (1.9%); found, 245.07 (100.0%), 244.07 (24.1%), 246.07 (7.6%), 245.08 (1.0%).
Crystals of 3b suitable for an X-ray diffraction study were obtained via the slow evaporation of a toluene solution or from a saturated aqueous solution.
Hexafluoroisopropylborane-1-butylimidazole adduct 3c was prepared using 1-butylimidazole (621 mg, 657 µL, 5.00 mmol). Yield: 1.24 g (4.31 mmol, 86%, calculated for 1) of a colorless liquid.
1H NMR (500.13 MHz, CD2Cl2): δ = 7.80 (s, 1H, NCHN), 7.11 (s, br, 1H, CH), 6.98(m, 1H, CH), 5.88 (tdm, 1H, CF2H, 2J(19F,1H) = 54.5 Hz, 3J(19F,1H) = 9.3 Hz), 4.00 (t, 2H, CH2, 3J(1H,1H) = 7.2), 2.40 (qm, 2H, BH2, 1J(11B,1H) = 97.5), 1.80 (m, 2H, CH2), 1.33 (m, 2H, CH2), 0.95 (t, 3H, CH3, 3J(1H,1H) = 7.4) ppm; 1H{11B} NMR (500.13 MHz, CD2Cl2): δ = 7.80 (s, 1H, NCHN), 7.11 (s, br, 1H, CH), 6.98(m, 1H, CH), 5.88 (tdm, 1H, CF2H, 2J(19F,1H) = 54.5 Hz, 3J(19F,1H) = 9.3 Hz), 4.00 (t, 2H, CH2, 3J(1H,1H) = 7.2), 2.40 (dq, 2H, BH2, 3J(19F,1H) = 27.2, 4J(19F,1H) = 2.7), 1.80 (m, 2H, CH2), 1.33 (m, 2H, CH2), 0.95 (t, 3H, CH3, 3J(1H,1H) = 7.4) ppm; 1H{19F} NMR (400.30 MHz, CD2Cl2): δ = 7.80 (s, 1H, NCHN), 7.11 (s, br, 1H, CH), 6.98(m, 1H, CH), 5.88 (m, 1H, CF2H), 4.00 (t, 2H, CH2, 3J(1H,1H) = 7.2), 2.40 (qm, 2H, BH2, 1J(11B,1H) = 97.5), 1.80 (m, 2H, CH2), 1.33 (m, 2H, CH2), 0.95 (t, 3H, CH3, 3J(1H,1H) = 7.4) ppm; 11B NMR (160.46 MHz, CD2Cl2): δ = −15.6 (t, 1B, BH2, 1J(11B,1H) = 97.5 Hz) ppm; 11B{1H} NMR (160.46 MHz, CD2Cl2): δ = −15.6 (s, 1B, BH2) ppm; 11B{19F} NMR (160.46 MHz, CD2Cl2): δ = −15.6 (t, 1B, BH2, 1J(11B,1H) = 97.5 Hz) ppm; 13C{1H} NMR (125.76 MHz, CD2Cl2): δ = 137.8 (s, 1C, NCHN), 128.3 (s, 1C, CH), 125.6 (qdt, 1C, CF3, 1J(19F,13C) = 283.7 Hz, 2J(19F,13C) = 26.0 Hz, 3J(19F,13C) = 4.8 Hz), 120.2 (s, 1C, CH), 115.4 (tdq, 1C, CF2H, 1J(19F,13C) = 247.0 Hz, 2J(19F,13C) = 27.0 Hz, 3J(19F,13C) = 2.9 Hz), 95.8 (d, br, 1C, CF, 1J(19F,13C) = 181.0 Hz), 49.1 (s, 1C, CH2), 32.7 (s, 1C, CH2), 19.8 (s, 1C, CH2) 13.5 (s, 1C, CH3) ppm; 13C{11B,1H} NMR (75.48 MHz, CD2Cl2): δ = 137.9 (s, 1C, NCHN), 128.2 (s, 1C, CH), 125.7 (qdt, 1C, CF3, 1J(19F,13C) = 283.7 Hz, 2J(19F,13C) = 26.0 Hz, 3J(19F,13C) = 4.8 Hz), 120.4 (s, 1C, CH), 115.5 (tdq, 1C, CF2H, 1J(19F,13C) = 247.0 Hz, 2J(19F,13C) = 27.0 Hz, 3J(19F,13C) = 2.9 Hz), 96.0 (dqt, 1C, CF, 1J(19F,13C) = 181.0 Hz, 2J(19F,13C) = 28.6 Hz, 2J(19F,13C) = 23.6 Hz), 49.1 (s, 1C, CH2), 32.7 (s, 1C, CH2), 19.8 (s, 1C, CH2) 13.5 (s, 1C, CH3) ppm; 13C{19F} NMR (125.76 MHz, CD2Cl2): δ = 137.8 (d, 1C, NCHN, 1J(13C,1H) = 214.3 Hz), 128.3 (dm, 1C, CH, 1J(13C,1H) = 198.7 Hz), 125.6 (s, 1C, CF3), 120.2 (dm, 1C, CH, 1J(13C,1H) = 195.9 Hz), 115.4 (dt, 1C, CF2H, 1J(13C,1H) = 188.8 Hz, 3J(13C,1H) = 3.3 Hz), 95.8 (m, br, 1C, CF), 49.1 (tm, 1C, CH2, 1J(13C,1H) = 141.3 Hz), 32.7 (tm, 1C, CH2, 1J(13C,1H) = 127.7 Hz), 19.8 (tm, 1C, CH2, 1J(13C,1H) = 126.0 Hz) 13.5 (qm, 1C, CH3, 1J(13C,1H) = 125.1 Hz) ppm; 19F NMR (376.82 MHz, CD2Cl2): δ = −74.1 (dtt, 3F, CF3, 3J(19F,19F) = 10.2 Hz, 4J(19F,19F) = 8.0 Hz, 4J(19F,1H) = 2.3 Hz), −129.7 (dm, 2F, CF2H, 2J(19F,1H) = 54.6 Hz), −205.7 (m, 1F, CF) ppm; 19F{1H} NMR (376.82 MHz, CD2Cl2): δ = −74.1 (dt, 3F, CF3, 3J(19F,19F) = 10.2 Hz, 4J(19F,19F) = 8.0 Hz), −129.7 (m, 2F, CF2H), −205.7 (m, 1F, CF) ppm; 19F{11B} NMR (470.59 MHz, CD2Cl2): δ = −74.1 (dtt, 3F, CF3, 3J(19F,19F) = 10.3 Hz, 4J(19F,19F) = 7.9 Hz, 4J(19F,1H) = 2.2 Hz), −129.7 (dm, 2F, CF2H, 2J(19F,1H) = 54.3 Hz), −205.7 (m, 1F, CF) ppm.
IR (ATR): 2412 cm−1 ((B–H)).
Raman: 2417 cm−1 ((B–H)).
Elemental analysis: Calculated (%) for C10H15BF6N2, C 41.70, H 5.25, N 9.73; found, C 41.76, H 5.41, N 10.51.
HMRS ((-)-APCI): m/z (isotopic abundance) calculated for deprotonated 3c C10H14BF6N2−: 287.12 (100.0%), 286.12 (24.8%), 288.12 (10.8%), 287.12 (2.7%); found, 287.12 (100.0%), 286.12 (24.3%), 288.12 (11.0%), 287.12 (0.4%).
Hexafluoroisopropyl-1-vinylimidazole adduct 3d was prepared using 1-vinylimidazole (470 mg, 452 µL, 5.00 mmol). Yield: 1.14 g (4.40 mmol, 88%, calculated for 1) of a colorless liquid.
1H NMR (500.13 MHz, CD2Cl2): δ = 8.02 (s, 1H, NCHN), 7.28 (m, 1H, CH), 7.19 (s, br, 1H, CH), 6.92 (dd, 1H, CHVn, 3J(1H,1H) = 15.7 Hz, 3J(1H,1H) = 8.7 Hz), 5.91 (tdq, 1H, CF2H, 2J(19F,1H) = 54.6 Hz, 3J(19F,1H) = 9.4 Hz, 4J(19F,1H) = 0.6 Hz), 5.56 (dd, 1H, CH2Vn, 3J(1H,1H) = 15.7 Hz, 3J(1H,1H) = 2.6 Hz), 5.26 (dd, 1H, CH2Vn, 3J(1H,1H) = 8.7 Hz, 3J(1H,1H) = 2.6 Hz), 2.43 (qm, 2H, BH2, 1J(11B,1H) = 99.5) ppm; 1H{11B} NMR (500.13 MHz, CD2Cl2): δ = 8.02 (s, 1H, NCHN), 7.28 (m, 1H, CH), 7.19 (s, br, 1H, CH), 6.92 (dd, 1H, CHVn, 3J(1H,1H) = 15.7 Hz, 3J(1H,1H) = 8.7 Hz), 5.91 (tdq, 1H, CF2H, 2J(19F,1H) = 54.6 Hz, 3J(19F,1H) = 9.4 Hz, 4J(19F,1H) = 0.6 Hz), 5.56 (dd, 1H, CH2Vn, 3J(1H,1H) = 15.7 Hz, 3J(1H,1H) = 2.6 Hz), 5.26 (dd, 1H, CH2Vn, 3J(1H,1H) = 8.7 Hz, 3J(1H,1H) = 2.6 Hz), 2.43 (dq, 2H, BH2, 3J(19F,1H) = 26.5, 4J(19F,1H) = 2.8) ppm; 1H{19F} NMR (400.30 MHz, CD2Cl2): δ = 8.02 (s, 1H, NCHN), 7.28 (m, 1H, CH), 7.19 (s, br, 1H, CH), 6.92 (dd, 1H, CHVn, 3J(1H,1H) = 15.7 Hz, 3J(1H,1H) = 8.7 Hz), 5.91 (m, 1H, CF2H), 5.56 (dd, 1H, CH2Vn, 3J(1H,1H) = 15.7 Hz, 3J(1H,1H) = 2.6 Hz), 5.26 (dd, 1H, CH2Vn, 3J(1H,1H) = 8.7 Hz, 3J(1H,1H) = 2.6 Hz), 2.43 (qm, 2H, BH2, 1J(11B,1H) = 99.5) ppm; 11B NMR (160.46 MHz, CD2Cl2): δ = −15.5 (t, 1B, BH2, 1J(11B,1H) = 99.5 Hz) ppm; 11B{1H} NMR (160.46 MHz, CD2Cl2): δ = −15.5 (s, 1B, BH2) ppm; 11B{19F} NMR (160.46 MHz, CD2Cl2): δ = −15.5 (t, 1B, BH2, 1J(11B,1H) = 99.5 Hz) ppm; 13C{1H} NMR (125.76 MHz, CD2Cl2): δ = 136.7 (s, 1C, NCHN), 129.0 (s, 1C, CH), 128.7 (s, 1C, CHVn), 125.5 (qdt, 1C, CF3, 1J(19F,13C) = 283.4 Hz, 2J(19F,13C) = 25.7 Hz, 3J(19F,13C) = 4.9 Hz), 117.4 (s, 1C, CH), 115.3 (tdq, 1C, CF2H, 1J(19F,13C) = 246.5 Hz, 2J(19F,13C) = 27.1 Hz, 3J(19F,13C) = 2.9 Hz), 107.6 (s, 1C, CHVn), 95.7 (d, br, 1C, CF, 1J(19F,13C) = 181.0 Hz) ppm; 13C{11B,1H} NMR (75.48 MHz, CD2Cl2): δ = 136.8 (s, 1C, NCHN), 128.9 (s, 1C, CH), 128.7 (s, 1C, CHVn), 125.5 (qdt, 1C, CF3, 1J(19F,13C) = 283.4 Hz, 2J(19F,13C) = 25.7 Hz, 3J(19F,13C) = 4.9 Hz), 117.5 (s, 1C, CH), 115.4 (tdq, 1C, CF2H, 1J(19F,13C) = 246.5 Hz, 2J(19F,13C) = 27.1 Hz, 3J(19F,13C) = 2.9 Hz), 107.5 (s, 1C, CHVn), 95.7 (dqt, 1C, CF, 1J(19F,13C) = 181.0 Hz, 2J(19F,13C) = 29.0 Hz, 2J(19F,13C) = 23.5 Hz) ppm; 13C{19F} NMR (125.76 MHz, CD2Cl2): δ = 136.7 (d, 1C, NCHN, 1J(13C,1H) = 217.1 Hz), 129.0 (dm, 1C, CH, 1J(13C,1H) = 200.0 Hz), 128.7 (dm, 1C, CHVn, 1J(13C,1H) = 184.1 Hz), 125.5 (s, 1C, CF3), 117.4 (dm, 1C, CH, 1J(13C,1H) = 198.9 Hz), 115.3 (dt, 1C, CF2H, 1J(13C,1H) = 188.8 Hz, 3J(13C,1H) = 3.3 Hz), 107.6 (dd, 1C, CHVn, 1J(13C,1H) = 167.1, 1J(13C,1H) = 159.4 Hz), 95.7 (m, br, 1C, CF) ppm; 19F NMR (376.82 MHz, CD2Cl2): δ = −74.1 (dtt, 3F, CF3, 3J(19F,19F) = 10.2 Hz, 4J(19F,19F) = 8.0 Hz, 4J(19F,1H) = 2.2 Hz), −129.6 (dm, 2F, CF2H, 2J(19F,1H) = 54.5 Hz), −205.8 (m, 1F, CF) ppm; 19F{1H} NMR (376.82 MHz, CD2Cl2): δ = −74.0 (dt, 3F, CF3, 3J(19F,19F) = 10.1 Hz, 4J(19F,19F) = 8.1 Hz), −129.6 (m, 2F, CF2H), −205.8 (m, 1F, CF) ppm; 19F{11B} NMR (470.59 MHz, CD2Cl2): δ = −74.1 (dtt, 3F, CF3, 3J(19F,19F) = 10.2 Hz, 4J(19F,19F) = 8.0 Hz, 4J(19F,1H) = 2.2 Hz, −129.6 (dm, 2F, CF2H, 2J(19F,1H) = 54.5 Hz), −205.8 (m, 1F, CF) ppm.
IR (ATR): 2415 cm−1 ((B–H)).
Raman: 2420 cm−1 ((B–H)).
Elemental analysis: Calculated (%) for C7H9BF6N2, C 37.25, H 3.52, N 10.89; found, C 37.57, H 3.66, N 11.29.
HMRS ((-)-APCI): m/z (isotopic abundance) calculated for deprotonated 3d C8H8BF6N2−: 257.07 (100.0%), 256.07 (24.8%), 258.07 (8.7%), 257.08 (2.1%); found, 257.07 (100.0%), 256.07 (23.3%), 258.07 (8.3%), 257.08 (0.3%).
Hexafluoroisopropyl-benzimidazole adduct 3e was prepared using benzimidazole (590 mg, 5.00 mmol). Yield: 1.41 g (4.44 mmol, 89%, calculated for 1) of a colorless liquid.
1H NMR (500.13 MHz, CD2Cl2): δ = 10.40 (s, br, 1H, NH), 8.39 (s, 1H, NCHN), 7.98 (m. 1H, CH), 7.61 (m, 1H, CH), 7.50 (m, 2H, CH), 6.00 (tdq, 1H, CF2H, 2J(19F,1H) = 54.5 Hz, 3J(19F,1H) = 9.4 Hz, 4J(19F,1H) = 0.6 Hz), 2.76 (m, 2H, BH2) ppm; 1H{11B} NMR (500.13 MHz, CD2Cl2): δ = 10.40 (s, br, 1H, NH), 8.39 (s, 1H, NCHN), 7.98 (m, 1H, CH), 7.61 (m, 1H, CH), 7.50 (m, 2H, CH), 6.00 (td, 1H, CF2H, 2J(19F,1H) = 54.5 Hz, 3J(19F,1H) = 9.4 Hz), 2.76 (dq, 2H, BH2, 3J(19F,1H) = 27.1, 4J(19F,1H) = 2.7) ppm; 1H{19F} NMR (400.30 MHz, CD2Cl2): δ = 10.47 (s, br, 1H, NH), 8.39 (s, 1H, NCHN), 7.98 (m. 1H, CH), 7.61 (m, 1H, CH), 7.50 (m, 2H, CH), 6.00 (m, 1H, CF2H, 2J(19F,1H) = 54.5 Hz, 3J(19F,1H) = 9.4 Hz, 4J(19F,1H) = 0.6 Hz), 2.76 (m, 2H, BH2) ppm; 11B NMR (160.46 MHz, CD2Cl2): δ = −17.1 (t, 1B, BH2, 1J(11B,1H) = 95.7 Hz) ppm; 11B{1H} NMR (160.46 MHz, CD2Cl2): δ = −17.1 (s, 1B, BH2) ppm; 11B{19F} NMR (160.46 MHz, CD2Cl2): δ = −17.1 (t, 1B, BH2, 1J(11B,1H) = 95.7 Hz) ppm; 13C{1H} NMR (125.76 MHz, CD2Cl2): δ = 142.2 (s, 1C, NCHN), 136.7 (s, 1C, CH), 131.1 (s, 1C, CH), 126.2 (s, 1C, CH), 125.7 (s, 1C, CH), 125.6 (qdt, 1C, CF3, 1J(19F,13C) = 283.5 Hz, 2J(19F,13C) = 26.0 Hz, 3J(19F,13C) = 5.0 Hz), 117.6 (m, 1C, CH), 115.4 (tdq, 1C, CF2H, 1J(19F,13C) = 246.5 Hz, 2J(19F,13C) = 26.9 Hz, 3J(19F,13C) = 2.9 Hz), 112.9 (s, 1C, CH), 96.5 (d, br, 1C, CF, 1J(19F,13C) = 180.5 Hz) ppm; 13C{11B,1H} NMR (75.48 MHz, CD2Cl2): δ = 142.2 (s, 1C, NCHN), 136.6 (s, 1C, CH), 131.2 (s, 1C, CH), 126.2 (s, 1C, CH), 125.7 (s, 1C, CH), 125.6 (qdt, 1C, CF3, 1J(19F,13C) = 283.6 Hz, 2J(19F,13C) = 25.9 Hz, 3J(19F,13C) = 4.9 Hz), 117.4 (m, 1C, CH), 115.5 (tdq, 1C, CF2H, 1J(19F,13C) = 246.5 Hz, 2J(19F,13C) = 26.9 Hz, 3J(19F,13C) = 2.9 Hz), 113.0 (s, 1C, CH), 96.6 (dqt, 1C, CF, 1J(19F,13C) = 181.0 Hz, 2J(19F,13C) = 28.9 Hz, 2J(19F,13C) = 23.7 Hz) ppm; 13C{19F} NMR (125.76 MHz, CD2Cl2): δ = 142.2 (dm, 1C, NCHN, 1J(13C,1H) = 214.3 Hz), 136.6 (m, 1C, CH), 131.2 (m, 1C, CH), 126.2 (dm, 1C, CH, 1J(13C,1H) = 162.9 Hz), 125.7 (s, 1C, CH, 1J(13C,1H) = 162.4 Hz), 125.6 (s, 1C, CF3), 117.6 (dm, 1C, CH, 1J(13C,1H) = 168.4 Hz), 115.3 (dt, 1C, CF2H, 1J(13C,1H) = 188.6 Hz, 3J(13C,1H) = 3.3 Hz), 112.9 (dm, 1C, CH, 1J(13C,1H) = 167.3 Hz), 96.5 (m, br, 1C, CF) ppm; 19F NMR (376.82 MHz, CD2Cl2): δ = −74.0 (dtt, 3F, CF3, 3J(19F,19F) = 10.2 Hz, 4J(19F,19F) = 8.0 Hz, 4J(19F,1H) = 2.2 Hz), −129.4 (dm, 2F, CF2H, 2J(19F,1H) = 54.4 Hz), −203.9 (m, 1F, CF) ppm; 19F{1H} NMR (376.82 MHz, CD2Cl2): δ = −74.0 (dt, 3F, CF3, 3J(19F,19F) = 10.2 Hz, 4J(19F,19F) = 8.0 Hz), −129.4 (m, 2F, CF2H), −203.9 (m, 1F, CF) ppm; 19F{11B} NMR (470.59 MHz, CD2Cl2): δ = −74.0 (dtt, 3F, CF3, 3J(19F,19F) = 10.3 Hz, 4J(19F,19F) = 7.9 Hz, 4J(19F,1H) = 2.2 Hz), −129.3 (dm, 2F, CF2H, 2J(19F,1H) = 54.4 Hz), −203.9 (m, 1F, CF) ppm.
IR (ATR): 3434 cm−1 ((N–H)), 2415 cm−1 ((B–H)).
Raman: 2420 cm−1, 2421 cm−1 ((B–H)).
Elemental analysis: Calculated (%) for C10H8BF6N2, C 42.59, H 3.22, N 9.93; found, C 42.73, H 3.39, N 10.28.
HMRS ((-)-APCI): m/z (isotopic abundance) calculated for deprotonated 3e C10H8BF6N2−: 281.07 (100.0%), 280.07 (24.8%), 282.07 (10.8%), 281.08 (2.7%); found, 281.07 (100.0%), 280.07 (24.8%), 282.07 (10.4%).
3.4.4. Hexafluoroisopropylborane-1,3-bis(2,6-diisopropylphenyl)-imidazolin-2-ylidene Adduct (4)
A solution of 1 (0.2 M in toluene, 5.00 mL, 1.00 mmol) was added to IDipp 1,3-bis-(2,6-diisopropylphenyl)-imidazolin-2-ylidene (389 mg, 1.00 mmol). After stirring for 48 h at room temperature, all volatiles were removed under reduced pressure. The solid residue was taken up in Et2O (25 mL) and washed with water (3 × 5 mL). Subsequently, the organic phase was dried over Na2SO4, filtered, and the organic solvent was removed under reduced pressure. After purification by column chromatography (CH2Cl2/hexane 85:15), the product was dried under vacuum. Yield: 321 mg (0.584 mmol, 58%, calculated for 1) of a colorless solid.
1H NMR (500.13 MHz, CD2Cl2): δ = 7.52 (t, 2H, p-CH, C3H6, 3J(1H,1H) = 7.7 Hz), 7.34 (d, 4H, m-CH, C3H6, 3J(1H,1H) = 7.8 Hz), 7.15 (s, 2H, CH, 3J(1H,1H) = 7.8 Hz), 5.95 (td, 1H, CF2H, 2J(19F,1H) = 54.5 Hz, 3J(19F,1H) = 9.5 Hz), 2.59 (sept, 4H, CH(CH3)2, 3J(1H,1H) = 6.9 Hz), 1.33 (dm, 12H, CH(CH)3(CH)3, 3J(1H,1H) = 6.7 Hz), 1.23 (m, 2H, BH2), 1.14 (dm, 12H, CH(CH)3(CH)3, 3J(1H,1H) = 6.7 Hz) ppm; 1H{11B} NMR (500.13 MHz, CD2Cl2): δ = 7.52 (t, 2H, p-CH, C3H6, 3J(1H,1H) = 7.7 Hz), 7.34 (d, 4H, m-CH, C3H6, 3J(1H,1H) = 7.8 Hz), 7.15 (s, 2H, CH, 3J(1H,1H) = 7.8 Hz), 5.35 (td, 1H, CF2H, 2J(19F,1H) = 54.5 Hz, 3J(19F,1H) = 9.5 Hz), 2.59 (sept, 4H, CH(CH3)2, 3J(1H,1H) = 6.9 Hz), 1.33 (dm, 12H, CH(CH)3(CH)3, 3J(1H,1H) = 6.7 Hz), 1.23 (m, 2H, BH2), 1.14 (dm, 12H, CH(CH)3(CH)3, 3J(1H,1H) = 6.7 Hz) ppm; 1H{19F} NMR (400.30 MHz, CD2Cl2): δ = 7.53 (t, 2H, p-CH, C3H6, 3J(1H,1H) = 7.7 Hz), 7.34 (d, 4H, m-CH, C3H6, 3J(1H,1H) = 7.8 Hz), 7.15 (s, 2H, CH, 3J(1H,1H) = 7.8 Hz), 5.35 (d, 1H, CF2H, 3J(19F,1H) = 9.5 Hz), 2.59 (sept, 4H, CH(CH3)2, 3J(1H,1H) = 6.9 Hz), 1.33 (dm, 12H, CH(CH)3(CH)3, 3J(1H,1H) = 6.7 Hz), 1.23 (m, 2H, BH2), 1.14 (dm, 12H, CH(CH)3(CH)3, 3J(1H,1H) = 6.7 Hz) ppm; 11B NMR (160.46 MHz, CD2Cl2): δ = −29.2 (t, 1B, BH2, 1J(11B,1H) = 88.1 Hz) ppm; 11B{1H} NMR (160.46 MHz, CD2Cl2): δ = −29.2 (s, 1B, BH2) ppm; 11B{19F} NMR (160.46 MHz, CD2Cl2): δ = −29.2 (t, 1B, BH2, 1J(11B,1H) = 88.1 Hz) ppm; 13C{1H} NMR (125.76 MHz, CD2Cl2): δ = 170.0 (m. br, 1C, NCN), 146.1 (m, 4C, ArC), 134.7 (m, 2C, ArC), 130.7 (m, 2C, ArCH), 125.6 (qdm, 1C, CF3, 1J(19F,13C) = 283.4 Hz, 2J(19F,13C) = 26.5 Hz), 124.4 (m, 4C, ArCH), 124.0 (m, 2C, NCH), 115.5 (tdq, 1C, CF2H, 1J(19F,13C) = 247.6 Hz, 2J(19F,13C) = 25.3 Hz, 3J(19F,13C) = 2.6 Hz), 96.7 (d, br, 1C, CF, 1J(19F,13C) = 177.6 Hz), 29.0 (s, 4C, iPrCH), 26.1 (s, 4C, iPrCH3), 22.3 (m, 4C, iPrCH3) ppm; 13C{19F} NMR (125.76 MHz, CD2Cl2): δ = 170.0 (m. br, 1C, NCN), 146.1 (m, 4C, ArC), 134.7 (m, 2C, ArC), 130.7 (dm, 2C, ArCH, 1J(13C,1H) = 158.2 Hz), 125.6 (s, 1C, CF3), 124.4 (dm, 4C, ArCH, 1J(13C,1H) = 123.7 Hz), 124.0 (dm, 2C, NCH, 1J(13C,1H) = 198.2 Hz), 115.5 (dm, 1C, CF2H, 1J(13C,1H) = 188.8 Hz), 96.7 (m, br, 1C, CF), 29.0 (dm, 4C, iPrCH, 1J(13C,1H) = 128.9 Hz), 26.1 (qm, 4C, iPrCH3, 1J(13C,1H) = 126.7 Hz), 22.3 (qm, 4C, iPrCH3, 1J(13C,1H) = 125.8 Hz) ppm; 19F NMR (376.82 MHz, CD2Cl2): δ = −74.1 (dt, 3F, CF3, 3J(19F,19F) ≈ 10.3 Hz, 4J(19F,19F) ≈ 7.9 Hz), −129.2 (dm, 2F, CF2H, 2J(19F,1H) = 53.8 Hz), −200.3 (m, 1F, CF) ppm; 19F{1H} NMR (376.82 MHz, CD2Cl2): δ = −74.1 (dt, 3F, CF3, 3J(19F,19F) ≈ 10.3 Hz, 4J(19F,19F) ≈ 7.9 Hz), −129.2 (m, 2F, CF2H), −200.3 (m, 1F, CF) ppm; 19F{11B} NMR (470.59 MHz, CD2Cl2): δ = −74.1 (dt, 3F, CF3, 3J(19F,19F) ≈ 10.3 Hz, 4J(19F,19F) ≈ 7.9 Hz), −129.2 (dm, 2F, CF2H, 2J(19F,1H) = 53.8 Hz), −200.3 (m, 1F, CF) ppm.
IR (ATR): 2430, 2402 cm−1 ((B–H)).
Raman: 2434, 2403 cm−1 ((B–H)).
Elemental analysis: Calculated (%) for C30H39BF6N2, C 65.22, H 7.12, N 5.07; found, C 65.13, H 7.13, N 5.03.
HMRS ((-)-APCI): m/z (isotopic abundance) calculated for deprotonated 3 C30H38BF6N2−: 551.30 (100.0%), 552.31 (32.4%), 550.31 (24.8%), 551.31 (5.6%), 553.31 (3.4%); found, 551.30 (100.0%), 552.31 (34.1%), 550.31 (25.8%), 553.31 (4.4%).
Crystals of 4 suitable for an X-ray diffraction study were obtained via the slow evaporation of a CH2Cl2 solution.
3.4.5. Benzyltriphenylphosphonium Hexafluoroisopropylcyanodihydridoborate ([BnPPh3]5)
Tetrabutylammonium cyanide (805 mg, 4.20 mmol) was added to a solution of 1 (0.2 M in toluene, 15 mL, 3.00 mmol). After stirring for 14 h at room temperature, all volatiles were removed under reduced pressure. Subsequently, a solution of [BnPPh3]Cl (1.17 g, 3.00 mmol) in ethanol (30 mL) and hydrochloric acid (0.5 M, 3 mL) was added to the solid residue. The product was precipitated from the solution by dropwise addition of water (200 mL). After stirring the suspension for 14 h at room temperature the product was filtered off, washed with water (3 × 20 mL) and diethyl ether (2 × 10 mL), and dried under vacuum. Yield: 750 mg (1.38 mmol, 35%, calculated for 1) of a colorless solid.
1H NMR (500.13 MHz, (CD3)2CO): δ = 7.95 (m, 3H, CH), 7.77 (m, 12H, CH), 7.35 (m, 1H, CH), 7.26 (m, 2H, CH), 7.11 (m, 2H, CH), 5.93 (tdm, 1H, CF2H, 2J(19F,1H) = 54.5 Hz, 3J(19F,1H) = 8.6 Hz), 5.10 (d, 2H, CH2, 2J(31P,1H) = 15.0 Hz), 1.14 (qd, 2H, BH2, 1J(11B,1H) = 92.6, 3J(19F,1H) = 29.2) ppm; 1H{11B} NMR (500.13 MHz, (CD3)2CO): δ = 7.95 (m, 3H, CH), 7.77 (m, 12H, CH), 7.35 (m, 1H, CH), 7.26 (m, 2H, CH), 7.11 (m, 2H, CH), 5.93 (tdm, 1H, CF2H, 2J(19F,1H) = 54.5 Hz, 3J(19F,1H) = 8.6 Hz), 5.10 (d, 2H, CH2, 2J(31P,1H) = 15.0 Hz), 1.14 (dm, 2H, BH2, 3J(19F,1H) = 29.2) ppm; 1H{19F} NMR (400.30 MHz, (CD3)2CO): δ = 7.94 (m, 3H, CH), 7.77 (m, 12H, CH), 7.34 (m, 1H, CH), 7.25 (m, 2H, CH), 7.12 (m, 2H, CH), 5.95 (m, 1H, CF2H), 5.10 (d, 2H, CH2, 2J(31P,1H) = 15.0 Hz), 1.20 (qd, 2H, BH2, 1J(11B,1H) = 92.6, 3J(19F,1H) = 29.2) ppm; 11B NMR (160.46 MHz, (CD3)2CO): δ = −33.3 (td, 1B, BH2, 1J(11B,1H) = 92.6 Hz, 2J(19F,11B) = 10.5 Hz) ppm; 11B{1H} NMR (160.46 MHz, (CD3)2CO): δ = −33.3 (d, 1B, BH2, 2J(19F,11B) = 10.5 Hz) ppm; 11B{19F} NMR (160.46 MHz, (CD3)2CO): δ = −33.3 (t, 1B, BH2, 1J(11B,1H) = 92.6 Hz) ppm; 13C{1H} NMR (125.76 MHz, (CD3)2CO): δ = 136.2 (d, 3C, p-Ph-CH, 4J(31P,13C) = 3.0 Hz), 135.1 (d, 12C, o-Ph-CH, 2J(31P,13C) = 9.8 Hz), 131.9 (d, 2C, o-Bn-CH, 3J(31P,13C) = 5.5 Hz), 131.1 (d, 12C, m-Ph-CH, 3J(31P,13C) = 12.6 Hz), 129.8 (d, 2C, m-Bn-CH, 4J(31P,13C) = 3.3 Hz), 129.5 (d, 1C, p-Bn-CH, 5J(31P,13C) = 3.8 Hz), 128.4 (d, 1C, i-Bn-CH, 2J(31P,13C) = 8.5 Hz), 126.8 (qdm, 1C, CF3, 1J(19F,13C) = 282.6 Hz, 2J(19F,13C) = 26.6 Hz), 118.7 (d, 3C, i-Ph-CH, 1J(31P,13C) = 85.8 Hz), 116.7 (tdm, 1C, CF2H, 1J(19F,13C) = 247.6 Hz, 2J(19F,13C) = 27.2 Hz), 97.0 (m, br, 1C, CF), 30.4 (d, 1C, PCH2, 1J(31P,13C) = 29.3 Hz) ppm (CN not detected); 13C{11B,1H} NMR (75.48 MHz, (CD3)2CO): δ = 136.0 (d, 3C, p-Ph-CH, 4J(31P,13C) = 3.0 Hz), 135.0 (d, 12C, o-Ph-CH, 2J(31P,13C) = 9.8 Hz), 131.8 (d, 2C, o-Bn-CH, 3J(31P,13C) = 5.5 Hz), 131.0 (d, 12C, m-Ph-CH, 3J(31P,13C) = 12.6 Hz), 129.7 (d, 2C, m-Bn-CH, 4J(31P,13C) = 3.3 Hz), 129.4 (d, 1C, p-Bn-CH, 5J(31P,13C) = 3.8 Hz), 128.3 (d, 1C, i-Bn-CH, 2J(31P,13C) = 8.5 Hz), 124.7 (qdm, 1C, CF3, 1J(19F,13C) = 282.6 Hz, 2J(19F,13C) = 26.6 Hz), 118.5 (d, 3C, i-Ph-CH, 1J(31P,13C) = 85.8 Hz), 116.5 (tdm, 1C, CF2H, 1J(19F,13C) = 247.6 Hz, 2J(19F,13C) = 27.2 Hz), 96.9 (dqt, 1C, CF, 1J(19F,13C) = 180.5 Hz, 2J(19F,13C) = 29.1 Hz, 2J(19F,13C) = 21.6 Hz), 30.3 (d, 1C, PCH2, 1J(31P,13C) = 48.1 Hz) ppm (CN not detected); 13C{19F} NMR (125.76 MHz, (CD3)2CO): δ = 136.2 (m, 3C, p-Ph-CH), 135.1 (m, 12C, o-Ph-CH), 131.9 (m, 2C, o-Bn-CH), 131.1 (m, 12C, m-Ph-CH), 129.8 (m, 2C, m-Bn-CH), 129.5 (m, 1C, p-Bn-CH), 128.4 (m, 1C, i-Bn-CH), 126.8 (m, 1C, CF3), 118.7 (m, 3C, i-Ph-CH), 116.7 (dt, 1C, CF2H, 1J(13C,1H) = 188.8 Hz, 3J(13C,1H) = 4.2 Hz), 97.0 (m, br, 1C, CF), 30.4 (m, 1C, PCH2) ppm (CN not detected); 19F NMR (376.82 MHz, (CD3)2CO): δ = −73.4 (m, 3F, CF3), −129.5 (dm, 2F, CF2H, 2J(19F,1H) = 54.2 Hz), −200.0 (m, 1F, CF) ppm; 19F{1H} NMR (376.82 MHz, (CD3)2CO): δ = −73.4 (m, 3F, CF3), −129.5 (m, 2F, CF2H), −200.0 (m, 1F, CF) ppm; 19F{11B} NMR (470.59 MHz, (CD3)2CO): δ = −73.5 (m, 3F, CF3), −129.7 (dm, 2F, CF2H, 2J(19F,1H) = 54.2 Hz), −200.3 (m, 1F, CF) ppm; 31P{1H} NMR (202.46 MHz, (CD3)2CO): δ = 23.0 (s, 1P, BnPh3P) ppm.
IR (ATR): 2390 cm−1 ((B–H)), 2183 cm−1 ((C≡N)).
Raman: 2395 cm−1 ((B–H)), 2187 cm−1 ((C≡N)).
Elemental analysis: Calculated (%) for C29H25BF6NP, C 64.11, H 4.64, N 2.58; found, C 64.30, H 4.84, N 2.54.
HMRS ((-)-ESI): m/z (isotopic abundance) calculated for C4H3BF6N−: 190.03 (100.0%), 189.03 (24.8%), 191.03 (4.3%); found, 190.03 (100%), 189.03 (24.7%), 191.03 (3.8%).
Crystals of [BnPPh3]5 suitable for an X-ray diffraction study were obtained from a saturated ethanol solution.
3.4.6. Tetramethylammonium Hexafluoroisopropylfluorodihydridoborate ([Me4N]6) and Benzyltriphenylphosphonium Hexafluoroisopropylfluorodihydridoborate ([BnPPh3]6)
Tetrametylammonium fluoride (931 mg, 10.0 mmol) was added to a solution of 1 (0.2 M in toluene, 50 mL, 10.0 mmol). After stirring for 72 h at room temperature, the suspension was filtered. The solid product was washed with toluene (2 × 50 mL) and dried under vacuum. Yield: 2.36 g (9.17 mmol, 92%, calculated for 1) of a colorless solid.
1H NMR (400.30 MHz, (CD3)2CO): δ = 5.94 (tdm, 1H, CF2H, 2J(19F,1H) = 54.6 Hz, 3J(19F,1H) = 8.8 Hz), 3.41 (s, 12H, CH3), 2.75 (m, br, 2H, BH2) ppm; 1H{11B} NMR (400.30 MHz, (CD3)2CO): δ = 5.94 (tdm, 1H, CF2H, 2J(19F,1H) = 54.6 Hz, 3J(19F,1H) = 8.8 Hz), 3.41 (s, 12H, CH3), 2.75 (m, 2H, BH2) ppm; 1H{19F} NMR (400.30 MHz, (CD3)2CO): δ = 5.95 (m, 1H, CF2H), 3.41 (s, 12H, CH3), 2.75 (m, br, 2H, BH2) ppm; 11B NMR (128.43 MHz, (CD3)2CO): δ = −3.3 (td, 1B, BH2, 1J(11B,1H) = 100.5 Hz, 1J(19F,11B) = 79.6 Hz) ppm; 11B{1H} NMR (128.43 MHz, (CD3)2CO): δ = −3.3 (d, 1B, BH2, 1J(19F,11B) = 79.6 Hz) ppm; 19F NMR (376.82 MHz, (CD3)2CO): δ = −72.3 (m, 3F, CF3), −131.2 (dm, 2F, CF2H, 2J(19F,1H) = 53.1 Hz), −209.4 (m, 1F, CF), −245.8 (m, 1F, BF) ppm; 19F{1H} NMR (376.82 MHz, (CD3)2CO): δ = −72.3 (m, 3F, CF3), −131.2 (m, 2F, CF2H), −209.4 (m, 1F, CF), −245.8 (m, 1F, BF) ppm.
[Me4N]6 (386 mg, 1.50 mmol) was dissolved in ethanol (20 mL) and [BnPPh3]Cl (583 mg, 1.50 mmol) was added. The product was precipitated from the solution by dropwise addition of water (150 mL). The product was filtered off, washed with water (3 × 20 mL), and dried under vacuum. Yield: 707 mg (1.32 mmol, 88%, calculated for [Me4N]6) of a colorless solid.
1H NMR (500.13 MHz, (CD3)2CO): δ = 7.94 (m, 3H, CH), 7.77 (m, 12H, CH), 7.34 (m, 1H, CH), 7.25 (m, 2H, CH), 7.11 (m, 2H, CH), 5.94 (tdm, 1H, CF2H, 2J(19F,1H) = 54.7 Hz, 3J(19F,1H) = 8.6 Hz), 5.07 (d, 2H, CH2, 2J(31P,1H) = 14.0 Hz), 2.85 (qm, 2H, BH2, 1J(11B,1H) = 100.5) ppm; 1H{11B} NMR (500.13 MHz, (CD3)2CO): δ = 7.94 (m, 3H, CH), 7.77 (m, 12H, CH), 7.34 (m, 1H, CH), 7.25 (m, 2H, CH), 7.11 (m, 2H, CH), 5.94 (tdm, 1H, CF2H, 2J(19F,1H) = 54.7 Hz, 3J(19F,1H) = 8.6 Hz), 5.07 (d, 2H, CH2, 2J(31P,1H) = 14.0 Hz), 2.85 (m, 2H, BH2) ppm; 1H{19F} NMR (400.30 MHz, (CD3)2CO): δ = 7.94 (m, 3H, CH), 7.77 (m, 12H, CH), 7.34 (m, 1H, CH), 7.25 (m, 2H, CH), 7.11 (m, 2H, CH), 5.94 (m, 1H, CF2H), 5.07 (d, 2H, CH2, 2J(31P,1H) = 14.0 Hz), 2.85 (qm, 2H, BH2, 1J(11B,1H) = 100.5) ppm; 11B NMR (160.46 MHz, (CD3)2CO): δ = −3.2 (td, 1B, BH2, 1J(11B,1H) = 100.5 Hz, 1J(19F,11B) = 79.6 Hz) ppm; 11B{1H} NMR (160.46 MHz, (CD3)2CO): δ = −3.2 (d, 1B, BH2, 2J(19F,11B) = 79.6 Hz) ppm; 11B{19F} NMR (160.46 MHz, (CD3)2CO): δ = −3.2 (t, 1B, BH2, 1J(11B,1H) = 100.5 Hz) ppm; 13C{1H} NMR (125.76 MHz, (CD3)2CO): δ = 136.1 (d, 3C, p-Ph-CH, 4J(31P,13C) = 3.0 Hz), 135.1 (d, 12C, o-Ph-CH, 2J(31P,13C) = 9.8 Hz), 132.0 (d, 2C, o-Bn-CH, 3J(31P,13C) = 5.6 Hz), 131.0 (d, 12C, m-Ph-CH, 3J(31P,13C) = 12.6 Hz), 129.8 (d, 2C, m-Bn-CH, 4J(31P,13C) = 3.3 Hz), 129.5 (d, 1C, p-Bn-CH, 5J(31P,13C) = 3.8 Hz), 128.5 (d, 1C, i-Bn-CH, 2J(31P,13C) = 8.5 Hz), 127.2 (qdm, 1C, CF3, 1J(19F,13C) = 283.2 Hz, 2J(19F,13C) = 26.7 Hz), 118.7 (d, 3C, i-Ph-CH, 1J(31P,13C) = 86.1 Hz), 117.0 (tdm, 1C, CF2H, 1J(19F,13C) = 248.5 Hz, 2J(19F,13C) = 26.7 Hz), 98.1 (m, br, 1C, CF), 30.2 (d, 1C, PCH2, 1J(31P,13C) = 48.1 Hz) ppm; 13C{11B,1H} NMR (75.48 MHz, (CD3)2CO): δ = 136.0 (d, 3C, p-Ph-CH, 4J(31P,13C) = 3.0 Hz), 135.0 (d, 12C, o-Ph-CH, 2J(31P,13C) = 9.8 Hz), 131.9 (d, 2C, o-Bn-CH, 3J(31P,13C) = 5.6 Hz), 131.0 (d, 12C, m-Ph-CH, 3J(31P,13C) = 12.6 Hz), 129.7 (d, 2C, m-Bn-CH, 4J(31P,13C) = 3.3 Hz), 129.4 (d, 1C, p-Bn-CH, 5J(31P,13C) = 3.8 Hz), 128.4 (d, 1C, i-Bn-CH, 2J(31P,13C) = 8.5 Hz), 127.2 (qdm, 1C, CF3, 1J(19F,13C) = 283.2 Hz, 2J(19F,13C) = 26.7 Hz), 118.6 (d, 3C, i-Ph-CH, 1J(31P,13C) = 86.1 Hz), 116.9 (tdm, 1C, CF2H, 1J(19F,13C) = 248.5 Hz, 2J(19F,13C) = 26.7 Hz), 98.1 (dm, 1C, CF, 1J(19F,13C) = 179.2 Hz), 30.1 (d, 1C, PCH2, 1J(31P,13C) = 48.1 Hz) ppm; 13C{19F} NMR (125.76 MHz, (CD3)2CO): δ = 136.1 (m, 3C, p-Ph-CH), 135.1 (m, 12C, o-Ph-CH), 132.0 (m, 2C, o-Bn-CH), 131.0 (m, 12C, m-Ph-CH), 129.8 (m, 2C, m-Bn-CH), 129.5 (m, 1C, p-Bn-CH), 128.5 (m, 1C, i-Bn-CH), 127.2 (m, 1C, CF3), 118.7 (m, 3C, i-Ph-CH), 117.0 (dt, 1C, CF2H, 1J(13C,1H) = 188.8 Hz, 3J(13C,1H) = 4.2 Hz), 98.1 (m, br, 1C, CF), 30.2 (m, 1C, PCH2) ppm; 19F NMR (376.82 MHz, (CD3)2CO): δ = −72.0 (m, 3F, CF3), −131.1 (dm, 2F, CF2H, 2J(19F,1H) = 53.8 Hz), −209.0 (m, 1F, CF), −245.3 (m, 1F, BF) ppm; 19F{1H} NMR (376.82 MHz, (CD3)2CO): δ = −72.0 (m, 3F, CF3), −131.1 (m, 2F, CF2H), −209.0 (m, 1F, CF), −245.3 (m, 1F, BF) ppm; 19F{11B} NMR (470.59 MHz, (CD3)2CO): δ = −72.0 (m, 3F, CF3), −131.1 (dm, 2F, CF2H, 2J(19F,1H) = 54.2 Hz), −208.9 (m, 1F, CF), −245.3 (tm, 1F, BF, 2J(19F,1H) = 43.5 Hz) ppm; 31P{1H} NMR (202.46 MHz, (CD3)2CO): δ = 23.0 (s, 1P, BnPh3P) ppm.
IR (ATR): 2311, 2241 cm−1 ((B–H)).
Raman: 2330, 2245 cm−1 ((B–H)).
Elemental analysis: Calculated (%) for C28H25BF7P, C 62.71, H 4.70; found, C 62.72, H 4.95.
HMRS ((-)-ESI): m/z (isotopic abundance) calculated for C3H3BF7−: 183.02 (100.0%), 182.03 (24.8%), 184.02 (3.2%); found, 183.02 (100.0%), 182.03 (24.8%), 184.02 (3.3%).
Crystals of [BnPPh3]6 suitable for an X-ray diffraction study were obtained from a saturated ethanol solution.
3.4.7. Benzyltriphenylphosphonium Hexafluoroisopropyltrifluoroborate ([BnPPh3]7)
[Me4N]6 (1.03 g, 4.00 mmol) was added to a solution of KHF2 (3.12 g, 40.0 mmol) in trifluoroacetic acid (5 mL) under gas evolution. After stirring for 30 min at room temperature, all volatiles were removed under reduced pressure. Subsequently, a solution of [BnPPh3]Cl (1.56 g, 4.00 mmol) in ethanol (20 mL) was added to the solid residue. The product was precipitated from the solution by dropwise addition of dilute hydrochloric acid (0.083 M, 300 mL). The product was filtered off, washed with diethyl ether (4 × 5 mL), and dried under vacuum. The solid product was crystallized by slow evaporation of an acetone solution. Yield: 1.86 g (3.25 mmol, 81%, calculated for [Me4N]6) of a colorless solid.
1H NMR (500.13 MHz, (CD3)2CO): δ = 7.94 (m, 3H, CH), 7.77 (m, 12H, CH), 7.34 (m, 1H, CH), 7.25 (m, 2H, CH), 7.11 (m, 2H, CH), 5.94 (tdm, 1H, CF2H, 2J(19F,1H) = 53.9 Hz, 3J(19F,1H) = 8.6 Hz), 5.08 (d, 2H, CH2, 2J(31P,1H) = 14.9 Hz) ppm; 1H{11B} NMR (500.13 MHz, (CD3)2CO): δ = 7.95 (m, 3H, CH), 7.77 (m, 12H, CH), 7.35 (m, 1H, CH), 7.26 (m, 2H, CH), 7.11 (m, 2H, CH), 5.94 (tdm, 1H, CF2H, 2J(19F,1H) = 53.9 Hz, 3J(19F,1H) = 8.6 Hz), 5.08 (d, 2H, CH2, 2J(31P,1H) = 14.9 Hz) ppm; 1H{19F} NMR (400.30 MHz, (CD3)2CO): δ = 7.95 (m, 3H, CH), 7.77 (m, 12H, CH), 7.35 (m, 1H, CH), 7.26 (m, 2H, CH), 7.11 (m, 2H, CH), 6.00 (m, 1H, CF2H), 5.07 (d, 2H, CH2, 2J(31P,1H) = 14.9 Hz) ppm; 11B NMR (160.46 MHz, (CD3)2CO): δ = 0.6 (qd, 1B, BF3, 1J(19F,11B) = 43.6 Hz, 2J(19F,11B) = 12.2 Hz) ppm; 11B{1H} NMR (160.46 MHz, (CD3)2CO): δ = 0.6 (qd, 1B, BF3, 1J(19F,11B) = 43.6 Hz, 2J(19F,11B) = 12.2 Hz) ppm; 11B{19F} NMR (160.46 MHz, (CD3)2CO): δ = 0.6 (s, 1B, BF3) ppm; 13C{1H} NMR (125.76 MHz, (CD3)2CO): δ = 136.2 (d, 3C, p-Ph-CH, 4J(31P,13C) = 3.1 Hz), 135.1 (d, 12C, o-Ph-CH, 2J(31P,13C) = 9.8 Hz), 132.0 (d, 2C, o-Bn-CH, 3J(31P,13C) = 5.5 Hz), 131.1 (d, 12C, m-Ph-CH, 3J(31P,13C) = 12.6 Hz), 129.9 (d, 2C, m-Bn-CH, 4J(31P,13C) = 3.3 Hz), 129.5 (d, 1C, p-Bn-CH, 5J(31P,13C) = 3.8 Hz), 128.5 (d, 1C, i-Bn-CH, 2J(31P,13C) = 8.5 Hz), 125.9 (qdm, 1C, CF3, 1J(19F,13C) = 283.0 Hz, 2J(19F,13C) = 25.3 Hz), 118.7 (d, 3C, i-Ph-CH, 1J(31P,13C) = 86.0 Hz), 115.9 (tdm, 1C, CF2H, 1J(19F,13C) = 247.0 Hz, 2J(19F,13C) = 26.3 Hz), 91.6 (m, br, 1C, CF), 30.3 (d, 1C, PCH2, 1J(31P,13C) = 48.1 Hz) ppm; 13C{11B,1H} NMR (75.48 MHz, (CD3)2CO): δ = 136.1 (m, br, 3C, p-Ph-CH), 135.0 (d, 12C, o-Ph-CH, 2J(31P,13C) = 9.8 Hz), 131.9 (d, 2C, o-Bn-CH, 3J(31P,13C) = 5.6 Hz), 131.0 (d, 12C, m-Ph-CH, 3J(31P,13C) = 12.6 Hz), 129.6 (d, 2C, m-Bn-CH, 4J(31P,13C) = 3.3 Hz), 129.4 (d, 1C, p-Bn-CH, 5J(31P,13C) = 3.8 Hz), 128.4 (d, 1C, i-Bn-CH, 2J(31P,13C) = 8.5 Hz), 125.8 (qdm, 1C, CF3, 1J(19F,13C) = 283.2 Hz, 2J(19F,13C) = 26.7 Hz), 118.5 (d, 3C, i-Ph-CH, 1J(31P,13C) = 86.1 Hz), 115.8 (tdm, 1C, CF2H, 1J(19F,13C) = 248.5 Hz, 2J(19F,13C) = 26.7 Hz), 91.5 (dm, 1C, CF, 1J(19F,13C) = 178.1 Hz), 30.1 (d, 1C, PCH2, 1J(31P,13C) = 48.1 Hz) ppm; 13C{19F} NMR (125.76 MHz, (CD3)2CO): δ = 136.2 (m, 3C, p-Ph-CH), 135.1 (m, 12C, o-Ph-CH), 132.0 (m, 2C, o-Bn-CH), 131.1 (m, 12C, m-Ph-CH), 129.9 (m, 2C, m-Bn-CH), 129.5 (m, 1C, p-Bn-CH), 128.5 (m, 1C, i-Bn-CH), 125.9 (m, 1C, CF3), 118.7 (m, 3C, i-Ph-CH), 115.9 (d, 1C, CF2H, 1J(13C,1H) = 189.9 Hz), 91.6 (qm, 1C, CF, 1J(13C,11B) = 67.7 Hz), 30.3 (m, 1C, PCH2) ppm; 19F NMR (376.82 MHz, (CD3)2CO): δ = −72.4 (m, 3F, CF3), −131.9 (dm, 2F, CF2H, 2J(19F,1H) = 53.0 Hz), −148.7 (qm, 1F, BF3, qm, 3F, BF3, 1J(19F,11B) = 43.6 Hz), −217.1 (m, 1F, CF) ppm; 19F{1H} NMR (376.82 MHz, (CD3)2CO): δ = −72.4 (m, 3F, CF3), −131.9 (m, 2F, CF2H), −148.7 (qm, 3F, BF3, 1J(19F,11B) = 43.6 Hz), −217.1 (m, 1F, CF) ppm; 19F{11B} NMR (470.59 MHz, (CD3)2CO): δ = −72.1 (m, 3F, CF3), −131.8 (dm, 2F, CF2H, 2J(19F,1H) = 53.0 Hz), −149.3 (qm, 1F, BF3, m, 3F, BF3), −217.4 (m, 1F, CF) ppm; 31P{1H} NMR (202.46 MHz, (CD3)2CO): δ = 22.9 (s, 1P, BnPh3P) ppm.
Elemental analysis: Calculated (%) for C28H23BF9P, C 58.77, H 4.05; found, C 58.71, H 4.27.
HMRS ((-)-ESI): m/z (isotopic abundance) calculated for C3HBF9−: 219.00 (100.0%), 218.01 (24.8%), 220.01 (3.2%); found, 219.00 (100.0%), 218.01 (26.0%), 220.01 (3.0%).
Crystals of [BnPPh3]7 suitable for an X-ray diffraction study were obtained from a saturated ethanol solution.